RxSight, Inc. (NASDAQ:RXST) Receives $37.90 Consensus Price Target from Analysts
RxSight, Inc. (NASDAQ:RXST – Get Free Report) has received an average rating of “Hold” from the ten analysts that are presently covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company. The […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) has received an average rating of “Hold” from the ten analysts that are presently covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company. The […]
